WO2023093966 - SILICA NANOPARTICLES IN TARGETED HUMAN CANCER THERAPY

National phase entry is expected:
Publication Number WO/2023/093966
Publication Date 01.06.2023
International Application No. PCT/EG2021/000038
International Filing Date 25.11.2021
Title **
[English] SILICA NANOPARTICLES IN TARGETED HUMAN CANCER THERAPY
[French] NANOPARTICULES DE SILICE DANS UNE THÉRAPIE ANTICANCÉREUSE HUMAINE CIBLÉE
Applicants **
YEHIA, Hesham, Mohamed, Abdelsalam 4 Abu Al Fawares Street - 7th District - Nasr City Cairo, EG
MOHAMED, Said Mahmoud Said 3 Kasr Elshamea Square Ancient Egypt Cairo, EG
Inventors
YEHIA, Hesham, Mohamed, Abdelsalam 4 Abu Al Fawares Street - 7th District - Nasr City Cairo, EG
MOHAMED, Said Mahmoud Said 3 Kasr Elshamea Square Ancient Egypt Cairo, EG
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
*
International Searching Authority
*
Applicant's Legal Status
*
*
*
*
Entry into National Phase under
*
Translation

Recalculate

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing900
EPO Filing, Examination5349
Japan Filing591
South Korea Filing482
USA Filing, Examination2710
MasterCard Visa

Total: 10032

The term for entry into the National Phase has expired. This quotation is for informational purposes only

Abstract[English] gel particles are responsible for antioxidant activity, implying that it can be employed as an antioxidant and anticancer for cancer prevention and treatment.
An unhandled error has occurred. Reload 🗙